Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

For Mental Health Awareness Week 2019, the Oxford Science Blog explores how the University of Oxford has been researching the potential of online psychological treatments to support better mental health care.

The effects of the internet revolution over the past decade alone has been astounding. From the palm of our hand, the top of our desks and in our pockets, we have drastically altered the way we conduct our everyday lives and enhanced our capabilities.

The scale of internet use alone is evidence enough of its effects. According to the Office for National Statistics, 90% of adults in the UK reported being regular internet users and virtually all adults aged 16 to 34 reported being recent internet users (99% in 2018 compared to 44% of adults aged over 75).

Internet driven technologies have enhanced most aspects of our everyday existence, but what’s the potential for harnessing this capability for better health and care? We are seeing both national and local policies that are emphasising the need for embracing a spectrum of internet driven technologies to support professionals and patients alike.

But what about mental health? This Mental Health Awareness Week, the scale of the mental health challenge is serving as an urgent reminder as to why we should be embracing innovation in tackling it.

Read more (Oxford Science Blog, University of Oxford website)

Similar stories

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.

Professor Susan Jebb appointed as Chair of the Food Standards Agency

Susan Jebb, Professor of Diet and Population Health in Oxford University’s Nuffield Department of Primary Care Health Sciences, has been appointed as the new Chair of the Food Standards Agency.